Alixorexton Granted Breakthrough Therapy Designation by U.S. FDA for the Treatment of Narcolepsy Type 1
DUBLIN–(BUSINESS WIRE)–Jan. 6, 2026– Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) ha...
Narcolepsy affects 1 in every 2,000 Americans and 3 million people worldwide.
It is estimated that up to 50% of patients with Narcolepsy may be undiagnosed.
Typical onset of Narcolepsy is between the ages of 10 and 20 years old, but can occur in early childhood.
On average, patients have 6 physician visits before receiving a Narcolepsy diagnosis.

Online Support GroupsFree, online support groups worldwide for people with Narcolepsy and their families. |


National SummitThis one-day summit is for people with Narcolepsy, their families, educators, clinicians and researchers. |

Clinical TrialsPatient engagement in clinical trials help find new ways to treat individuals with Narcolepsy. |

Annual Family WeekendChildren & Teens with Narcolepsy can meet others experiencing the same symptoms and challenges. |

Join Our TeamDo you share our passion for advocating on behalf of those with Narcolepsy? |
DUBLIN–(BUSINESS WIRE)–Jan. 6, 2026– Alkermes plc (Nasdaq: ALKS) today announced that the U.S. Food and Drug Administration (FDA) ha...
PLYMOUTH MEETING, Pa.–(BUSINESS WIRE)–Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced strong preliminary, unaudited net....
The schedule for Wake Up Narcolepsy’s 2026 National Summit in Chicago, Illinois, has just been......
Join Wake Up Narcolepsy (WUN) at the Center for Courageous Kids (CCK) in Scottsville, Kentucky,......